Back

Risk of myocardial infarction with coronary artery bypass grafting versus percutaneous coronary intervention: a systematic review and meta-analysis of fifteen randomised trials

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Cardiovascular surgery Coronary Arteries ESC Premium Access ESC Congress 2019

About the speaker

Photo
Assistant Professor Pil Hyung Lee

Asan Medical Center, Seoul (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Doctor T. Inoue (Tokyo, JP)
Abstract
Presentation thumbnail
Doctor C. Koo (Singapore, SG)
Abstract
Presentation thumbnail
Doctor E. Rosello-Lleti (Valencia, ES)
Abstract Slides
Presentation thumbnail
Professor F. Lucchese (Happy Harbor, BR)
Abstract Slides
Presentation thumbnail
Professor P. Sulzgruber (Krems an der Donau, AT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Cardiovascular surgery

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Coronary artery bypass grafting versus percutaneous coronary intervention for left main disease in chronic kidney disease patients: A meta-analysis
28 August 2020
thumbnail
Congress Presentation
Reevaluated role of outpatient cardiovascular rehabilitation on clinical outcomes after acute myocardial infarction: a meta-analysis of European randomized clinical trials
4 April 2025
thumbnail
Congress Presentation
Post-discharge major bleeding, myocardial infarction and mortality risk after coronary artery bypass grafting: A nationwide cohort study from the SWEDEHEART registry
27 August 2021
thumbnail
Congress Presentation
Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources